Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

354 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of Immune Checkpoint Inhibitors in SMARCA4-Deficient Thoracic Tumor.
Shinno Y, Yoshida A, Masuda K, Matsumoto Y, Okuma Y, Yoshida T, Goto Y, Horinouchi H, Yamamoto N, Yatabe Y, Ohe Y. Shinno Y, et al. Among authors: horinouchi h. Clin Lung Cancer. 2022 Jul;23(5):386-392. doi: 10.1016/j.cllc.2022.03.005. Epub 2022 Apr 29. Clin Lung Cancer. 2022. PMID: 35618627
Innovator and generic cisplatin formulations: comparison of renal toxicity.
Sekine I, Kubota K, Tamura Y, Asahina H, Yamada K, Horinouchi H, Nokihara H, Yamamoto N, Tamura T. Sekine I, et al. Among authors: horinouchi h. Cancer Sci. 2011 Jan;102(1):162-5. doi: 10.1111/j.1349-7006.2010.01764.x. Epub 2010 Nov 5. Cancer Sci. 2011. PMID: 21054679 Free article.
Phase I study of concurrent high-dose three-dimensional conformal radiotherapy with chemotherapy using cisplatin and vinorelbine for unresectable stage III non-small-cell lung cancer.
Sekine I, Sumi M, Ito Y, Horinouchi H, Nokihara H, Yamamoto N, Kunitoh H, Ohe Y, Kubota K, Tamura T. Sekine I, et al. Among authors: horinouchi h. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):953-9. doi: 10.1016/j.ijrobp.2011.01.008. Epub 2011 Mar 4. Int J Radiat Oncol Biol Phys. 2012. PMID: 21377282 Clinical Trial.
Acute radiation esophagitis caused by high-dose involved field radiotherapy with concurrent cisplatin and vinorelbine for stage III non-small cell lung cancer.
Kuroda Y, Sekine I, Sumi M, Sekii S, Takahashi K, Inaba K, Horinouchi H, Nokihara H, Yamamoto N, Kubota K, Murakami N, Morota M, Mayahara H, Ito Y, Tamura T, Nemoto K, Itami J. Kuroda Y, et al. Among authors: horinouchi h. Technol Cancer Res Treat. 2013 Aug;12(4):333-9. doi: 10.7785/tcrt.2012.500319. Epub 2013 Jan 25. Technol Cancer Res Treat. 2013. PMID: 23369154 Free article.
354 results